Fecal microbiota transplant treatment for most microbiome-associated diseases has not been rigorously studied in humans — and any such studies would be subject to regulation by the Food and Drug Administration.
Fecal microbiota transplant treatment for most microbiome-associated diseases has not been rigorously studied in humans — and any such studies would be subject to regulation by the Food and Drug Administration.